Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1997-01-15
1999-01-05
Fredman, Jeffrey
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 6, 435 911, 435 912, 435 9151, 536 231, 536 243, 536 2431, 536 2452, 536 2433, 436 63, 436501, 436601, C12Q 170, C12Q 168, C12P 1934, C07H 2104
Patent
active
058560866
ABSTRACT:
The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 5008182 (1991-04-01), Sninsky et al.
patent: 5409810 (1995-04-01), Larder et al.
patent: 5631128 (1997-05-01), Kozal et al.
patent: 5650268 (1997-07-01), Kozal et al.
Eron et al., "Susceptibility testing by polymerase chain DNA quantitation: A method to measure drug resistance of human immunodeficiency virus type 1 isolates", Proc. Natl. Acad. Sci. 89:3241-3245, Apr. 1992.
Aoki et al., 1990, "Quantitive Analysis of HIV-1 Proviral DNA in Peripheral Blood Monouclear Cells from Patients with AIDS or ARC: Decrease of Proviral DNA Content Following Treatment with 2', 3'-Dideoxyinosine (ddl)" AIDS Res. Hum. Retroviruses 6: 1331-1339.
Bagnarelli et al., 1991, "Detection of Human Immunodeficiency Virus Type 1 Genomic RNA in Plasma Samples by Reverse-Transcription Polymerase Chain Reaction" J. Med. Virol. 34:89-95.
Boucher et al., 1990, "Zidovudine Sensitivity of Human Immunodefiency Viruses From High-Risk, Symptom-Free Individuals During Therapy" Lancet 336:585-590.
Boucher et al., 1992, "Ordered Appearance of Zidovudine Resistance Mutations During Treatment of 18 Human Immunodeficiency Virus-Positive Subjects" J. Infect. Dis. 165:105-110.
Bush et al., 1992 "Detection of Human Immunideficiency Virus Type 1 RNA in Plasma Samples from High-Risk Pediatric Patients by Using the Self-Sustained Sequence Replication Reaction" J. Clin. Microbiology 30(2): 281-286.
Chomczynski et al., 1987, "Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction" Anal. Biochem. 162:156-159.
Coombs et al., 1989, "Plasma Viremi in Human Immunodeficiency Virus Infection" N. Eng. J. Med. 321:1626-1631.
Coyle et al., 1990, "Detection of Human Immunodeficiency Virus in Plasma by RNA Directed Polymerase Chain Reaction in a Cohort of Hemophilliacs" Clin. Res. 38:778a (Abstr.).
Daar et al., 1991, "Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection" N. Engl. J. Med. 324: 961-964.
Ehrnst et al., 1988, "Efficient Isolation of HIV From Plasma During Different Stages of HIV Infection" J. Med. Virol. 26:23-32.
Eron JJ et al., "Pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield mutiply resitant human immunodeficiency virus type 1 islolates in vivo," Antimicrob. Agents Chemother. (1993); 37:1480-1487.
Escaich et al., 1991, "Plasma Viraemia as a marker of Viral Replication in HIV-Infected Individuals" AIDS 5:1189-1193.
Fischel et al., 1990, "A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Aquired Immunodeficiency Syndrome" N. Engl. J. Med. 323:1009-1014.
Gu Z et al., "Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2'3'-dideoxycytidine,"J. Virol. (1992); 66:7128-7135.
Henrard et al., 1992, "A Sensitive Viral Capture Assay for Detection of Plasma viremia in HIV-Infected Individuals" AIDS Res. Hum. Retroviruses 8:47-52.
Hewlett et al., 1988, "Detection in Plasma of HIV-1 Specific DNA and RNA by Polymerase Chain Reaction Before and After Seroconversion"J. Clin. Immunoassay 11:161-164.
Ho et al., 1989, "Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons" N. Engl. J. Med. 321:1621-1625.
Holodniy et al., 1991, "Inhibition of Human Immunodeficiency Virus Gene Amplification by Heparin" J. Clin. Microbiol. 29: 676-679.
Holodniy et al., 1991, "Reduction in Plasma Human Immunodeficiency Virus Ribonucleic Acid after Dideoxynucleoside Therapy as Determined by the Polymerase Chain Reaction" J. Clin. Invest. 88:1755-1759.
Holodniy et al., 1991, "Detection and Quantification of Human Imunodeficiency Virus RNA in Patient Serum by Use of the Polymerase Chain Reaction" J. Infect. Dis. 163:862-866.
Japour et al., 1991, "Detection of Human Immunodeficiency Virus Type 1 Clinical Isolates With Reduced Sensitivity to Zidovudine and Dideoxyinsine by RNA-RNA Hybridization" Proc. Natl. Acad. Sci. USA 88:3092-3096.
Karpas et al., 1990, "Polymerase Chain Reaction Evidence for Human Immunodeficiency Virus 1 Neutralization by Passive Immunization in Patients With AIDS and AIDS-related Complex" Proc. Natl. Acad. Sci. USA 87:7613-7617.
Kawaski, 1990, "In PCR Protocols: A Guide to Methods and Applications" pp. 21-27, M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White, eds. Academic Press, Berkeley, California.
Kellam et al., 1992, "Fifth Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Contributes to the Developement of High-Level Resistance to Zidovudine" Proc. Natl. Acad. Sci. USA 89: 1934-1938.
Kellog et al., 1990, "In PCR Protocols: A Guide to Methods and Applications"pp. 337-347, M. A. Innis, D. H. Gefland, J. J. Sninsky, and T. J. White, eds. Academic Press, Berkely, California.
Kusumi et al., 1992, "Human Immunodeficiency Virus Type 1 Envolope Gene Structure and Diversity In Vivo and After Cocultivation In Vitro" J. Virol. Methods 66:875-885.
Land et al., 1990, "Decreased In Vitro Susceptibility to Zidocudine of HIV Isolates Obtained from Patients with AIDS" J. Infect. Dis. 161:326-329.
Larder et al., 1989, "HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy" Science 243:1731-1734.
Larder et al., 1991, "Zidovudine Resistance Predicted Predicted by Direct Detection of Mutations in DNA From HIV-Infected Lymphocytes" AIDS 5:137-144.
Larder et al., 1989, "Mulitple Mutations in Hiv-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)" Science 246:1155-1158.
Levenson et al., 1990, "In PCR Protocols: A Guide to Methods and Applications" pp. 99-112, M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White, eds. Academic Press, Berkely, California.
McElrath et al., 1991, "Latent HIV-1 Infection in Enriched Populations of Blood Monocytes and T Cells from Seropositive Patients" J. Invest. 87:27-30.
Meyerhans et al., 1989, "Temporal Fluctuations in HIV Quasispecies In Vivo Are Not Reflected by Sequential HIV Isloations" Cells 58:901-910.
Murakawa et al., 1988, "Direct Detection of HIV-1 RNA from AIDS and Arc Patient Samples," DNA 7(4):287-295.
Ottman et al., 1991, "The Polymerase Chain Reaction for the Detection of HIV-1 Genomic RNA in Plasma From Infected Individuals" J. Virol Methods 31:273-284.
Richman et al., 1991, "Detection of Mutations Associated with Zidovudine Resistance in Human Immunodeficiency Virus by Use of the Polymerase Chain Reaction" J. Infect. Dis. 164:1075-1081.
Richman et al., 1990, "Effect of Stage of Disease and Drug Dose on Zidovudine Susceptibilities of Isloates of Human Immunodeficiency Virus" J. AIDS. 3:743-746.
Rooke et al., 1989 "Isolation of Drug-Resistant Variants of HIV-1 From Patients on Long-Term Zidovudine Therapy" AIDS 3:411-415.
Semple et al., 1991, "Direct Measurement of Viraemia in Patients Infected With HIV-1 and Its Relationship to Disease Progression and Zidovudine Therapy" J. Virol. Methods 35:38-45.
Shafer RW et al., "Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations," J. Infect. Dis. (1994); 169:722-729.
Shirasaka T et al., "Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine; an in vitro comparative study," Proc. Natl. Acad. Sci. USA (1993); 90:562-566.
St. Clair MH et al., "Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase," Science (1991); 253:1557-1559.
Stratagene catalog, (1988), p. 39.
Tersmette et al., 1989, "Association b
Kozal Michael J.
Merigan Thomas C..
Fredman Jeffrey
Leland Stanford Junior University
LandOfFree
Polymerase chain reaction assays for monitoring antiviral therap does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymerase chain reaction assays for monitoring antiviral therap, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymerase chain reaction assays for monitoring antiviral therap will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-860907